Efecto de la variante Ómicron sobre la incidencia y la letalidad durante la 6.ª onda epidémica COVID-19 en España(Pag.-e 102073)

  1. A. Serrano-Cumplido
  2. A. Ruíz-García 1
  3. A. del Rio-Herrero 2
  4. P.B. Antón-Eguía 3
  5. R.M. Micó-Pérez 4
  6. A. Calderón-Montero 5
  7. E. Romero-Rodríguez 6
  8. A. Segura-Fragoso 7
  9. V. Martín-Sánchez 8
  1. 1 Centro de Salud Universitario Pinto, Universidad Europea de Madrid, Pinto, Madrid, España
  2. 2 Hospital Alto Deba, Osakidetza, Arrasate, Guipúzcoa, España
  3. 3 Hospital de Manacor, Manacor, Islas Baleares, España
  4. 4 Centro de Salud Fontanars dels Alforins, Fontanars dels Alforins, Valencia, España
  5. 5 Consorcio de Investigación Biomédica en Epidemiología y Salud Pública (CIBERESP), Madrid, España
  6. 6 Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, España
  7. 7 Universidad de Castilla-La Mancha, Talavera de la Reina, Toledo, España
  8. 8 Universidad de León
    info

    Universidad de León

    León, España

    ROR https://ror.org/02tzt0b78

Mostrar afiliacións +
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Ano de publicación: 2024

Número: 2

Páxinas: 8-8

Tipo: Artigo

DOI: 10.1016/J.SEMERG.2023.102073 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Semergen: revista española de medicina de familia

Resumo

The COVID-19 pandemic has strained healthcare systems globally. The successive epidemic waves have shown different characteristics. The Omicron variant of SARS-CoV-2 modified the epidemic behavior that previous variants had followed. The aim of this analysis was to determine the epidemiological characteristics of COVID-19 during the sixth epidemic wave and its differences according to the predominance of the Delta or Omicron variants. The epidemiological data corresponding to the sixth wave of the epidemic published by official organizations were analyzed, and the cumulative incidence of infection (CI-I) and case fatality rates (CFR) were calculated, both for Spain as a whole and for the different Autonomous Communities, in the population as a whole and by age groups. The results showed that the CI-I was higher with the Ómicron variant (10.89% vs 0.75% with Delta) while the CFR was higher with the Delta variant (4.2‰ vs 1.3‰ with Ómicron), as well as a higher rate of hospitalization and ICU admission with the Delta variant.

Referencias bibliográficas

  • F.P. Lyngse, L.H. Mortensen, M.J. Denwood, L.E. Christiansen, C.H. Møller, R.L. Skov, et al. SARS-CoV-2 Omicron VOC Transmission in Danish Households medRxiv (2021), 10.1101/2021.12.27.21268278 View article Google Scholar
  • F.P. Lyngse, C.T. Kirkeby, M. Denwood, L.E. Christiansen, K. Mølbak, C.H. Møller, et al. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Household medRxiv (2022), 10.1101/2022.01.28.22270044 View article Google Scholar
  • N. Garrett, A. Tapley, J. Andriesen, I. Seocharan, L.H. Fisher, L. Bunts, et al. High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron medRxiv (2021), 10.1101/2021.12.20.21268130 View article Google Scholar
  • T.R. Pak, C. Rhee, R. Wang, M. Klompas Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland JAMA Intern Med (2023), pp. E1-E3, 10.1001/jamainternmed.2023.1261 View PDF This article is free to access. Google Scholar
  • A. Ruiz-García, F. Vitelli-Storelli, A. Serrano-Cumplido, A. Segura-Fragoso, A. Calderón-Montero, V. Martín-Sánchez Tasas de letalidad por SARS-CoV-2 durante la segunda onda epidémica en España según Comunidades Autónomas Semergen (2022), 10.1016/j.semerg.2022.02.004 View article Google Scholar
  • F. Vitelli-Storelli, V. Martín-Sánchez, A. Ruíz-García, A. Serrano-Cumplido, R. Micó-Pérez, A. Barquilla-García Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination Semergen (2023), 10.1016/j.semerg.2023.102026 View PDF Your institution provides access to this article. Google Scholar
  • A.C. Ulloa, S.A. Buchan, N. Daneman, K.A. Brown Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada JAMA (2022), 10.1001/jama.2022.2274 View PDF This article is free to access. Google Scholar
  • F. Abdullah, J. Myers, D. Basu, G. Tintinger, V. Ueckermann, M. Mathebula, et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, South Africa Int J Infect Dis, 116 (2022), pp. 38-42, 10.1016/j.ijid.2021.12.357 View PDFView articleView in ScopusGoogle Scholar
  • S.A. Madhi, G. Kwatra, J.E. Myers, W. Jassat, N. Dhar, C.K. Mukendi, et al. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa N Engl J Med, 386 (2022), pp. 1314-1326, 10.1056/NEJMoa2119658 View articleView in ScopusGoogle Scholar
  • Y. Araf, F. Akter, Y. Tang, R. Fatemi, S.A. Parvez, C. Zheng, et al. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines J Med Virol, 94 (2022), pp. 1825-1832, 10.1002/jmv.27588 View PDF Your institution provides access to this article. View in ScopusGoogle Scholar
  • Y. Liu, J. Rocklöv The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta J Travel Med, 29 (2022), pp. 1-4, 10.1093/jtm/taac037 View PDF This article is free to access. Google Scholar
  • Y. Liu, J. Rocklöv The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus J Travel Med, 28 (2021), pp. 1-3, 10.1093/jtm/taab124 View PDF This article is free to access. Google Scholar
  • K. Ito, C. Piantham, H. Nishiura Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark J Med Virol, 94 (2022), pp. 2265-2268, 10.1002/jmv.27560 View PDF This article is free to access. View in ScopusGoogle Scholar
  • N. Wolter, W. Jassat, S. Walaza, R. Welch, H. Moultrie, M. Groome, et al. Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa medRxiv (2021), 10.1101/2021.12.21.21268116 View article Google Scholar
  • C. Maslo, R. Friedland, M. Toubkin, A. Laubscher, T. Akaloo, B. Kama Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves JAMA (2021), 10.1001/jama.2021.24868 View PDF This article is free to access. Google Scholar
  • M.-A. Davies, R. Kassanjee, P. Rosseau, E. Morden, L. Johnson, W. Solomon, et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province South Africa medRxiv. (2022), 10.1101/2022.01.12.22269148 View article Google Scholar
  • L. Wang, N.A. Berger, D.C. Kaelber, P.B. Davis, N.D. Volkow, R. Xu Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US JAMA Pediatrics (2022), 10.1001/jamapediatrics.2022.0945 View PDF This article is free to access. Google Scholar
  • V. Hall, S. Foulkes, F. Insalata, P. Kirwan, A. Saei, A. Atti, et al. Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection N Engl J Med (2022), 10.1056/NEJMoa2118691 View article Google Scholar
  • C. Maslo, R. Friedland, M. Toubkin, A. Laubscher, T. Akaloo, B. Kama Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves JAMA (2021), 10.1001/jama.2021.24868 View PDF This article is free to access. Google Scholar
  • N. Wolter, W. Jassat, S. Walaza, R. Welch, H. Moultrie, M. Groome, et al. Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa medRxiv (2021), 10.1101/2021.12.21.21268116 View article Google Scholar
  • N. Wolter, W. Jassat, DATCOV-Gen, A. von Gottberg, C. Cohen Clinical severity of Omicron sub-lineage BA.2 compared to BA.1 in South Africa medRxiv (2022), 10.1101/2022.02.17.22271030 View article Google Scholar
  • S. Collie, J. Nayager, L. Bamford, L.-G. Bekker, M. Zylstra, G. Gray Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa N Engl J Med, 387 (2022), pp. 1332-1333, 10.1056/NEJMc2210093 View articleView in ScopusGoogle Scholar
Fonte de datos: Dialnet